News News Source Blog May 14, 2026 ASGCT and Orphan Therapeutics Accelerator Launch CGTxchange -- A First-of-Its-Kind Marketplace to Reactivate Promising Shelved Cell and Gene Therapy Programs May 14, 2026 Read more → May 14, 2026 May 11, 2026 AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases May 11, 2026 Read more → May 11, 2026 February 25, 2026 P4ML Becomes Founding Member of Orphan Therapeutics Accelerator (OTXL) to Support Broader Global Access to Ultra-Rare Disease Treatments February 25, 2026 Read more → February 25, 2026 January 7, 2026 ASGCT and Orphan Therapeutics Accelerator Launch CGTxchange - A First-of-Its-Kind Marketplace to Reactivate Promising Shelved Cell and Gene Therapy Programs January 7, 2026 Read more → January 7, 2026 December 15, 2025 Fondazione Telethon and Orphan Therapeutics Accelerator Sign Memorandum of Understanding to Pioneer Nonprofit Commercial Access Model for Ultra-Rare Disease Gene Therapy in the US December 15, 2025 Read more → December 15, 2025 August 12, 2025 Orphan Therapeutics Accelerator Launches Orphan Therapies, a Non-Profit Biotech Dedicated to Commercializing Ultra-Rare Disease Treatments August 12, 2025 Read more → August 12, 2025 May 14, 2025 Viralgen Joins Orphan Therapeutics Accelerator Clinical Development Network as a Manufacturing Partner to Advance Rare Disease Therapies May 14, 2025 Read more → May 14, 2025 April 23, 2025 Orphan Therapeutics Accelerator Announces Foundational Partnerships April 23, 2025 Read more → April 23, 2025 In the Media News Source Blog May 14, 2026 ASGCT and Orphan Therapeutics Accelerator Launch CGTxchange -- A First-of-Its-Kind Marketplace to Reactivate Promising Shelved Cell and Gene Therapy Programs May 14, 2026 Read more → May 14, 2026 May 11, 2026 AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases May 11, 2026 Read more → May 11, 2026 February 25, 2026 P4ML Becomes Founding Member of Orphan Therapeutics Accelerator (OTXL) to Support Broader Global Access to Ultra-Rare Disease Treatments February 25, 2026 Read more → February 25, 2026 January 7, 2026 ASGCT and Orphan Therapeutics Accelerator Launch CGTxchange - A First-of-Its-Kind Marketplace to Reactivate Promising Shelved Cell and Gene Therapy Programs January 7, 2026 Read more → January 7, 2026 December 15, 2025 Fondazione Telethon and Orphan Therapeutics Accelerator Sign Memorandum of Understanding to Pioneer Nonprofit Commercial Access Model for Ultra-Rare Disease Gene Therapy in the US December 15, 2025 Read more → December 15, 2025 August 12, 2025 Orphan Therapeutics Accelerator Launches Orphan Therapies, a Non-Profit Biotech Dedicated to Commercializing Ultra-Rare Disease Treatments August 12, 2025 Read more → August 12, 2025 May 14, 2025 Viralgen Joins Orphan Therapeutics Accelerator Clinical Development Network as a Manufacturing Partner to Advance Rare Disease Therapies May 14, 2025 Read more → May 14, 2025 April 23, 2025 Orphan Therapeutics Accelerator Announces Foundational Partnerships April 23, 2025 Read more → April 23, 2025